[Antipsychotics of different clinical/pharmacological groups in treatment of negative disorders in schizophrenia].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova / Ministerstvo zdravookhraneniia i meditsinskoi promyshlennosti Rossiiskoi Federatsii, Vserossiiskoe obshchestvo nevrologov [i] Vserossiiskoe obshchestvo psikhiatrov

PubMedID: 25513361

The possibility of using different anti psychotics in treatment of negative disorders in schizophrenia is considered. Mechanisms of the development of "antinegative" effect during treatment with typical neuroleptics, atypical neuroleptics with dopamine-serotonin activity and atypical neuroleptics (partial dopamine receptor agonists) are analyzed. Their efficacy is discussed in the comparative context. In conclusion, a differential approach to schizophrenia treatment is suggested.